A Study of IBI363 in Subjects With Advanced Melanoma
Clinical trial NCT06081920 · RECRUITING
Trial details
- NCT number
- NCT06081920
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-19
- Primary completion
- 2028-10-19
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.